Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients

Journal of Biomedical Science

Volumn 11, Issue 4, 2004, Pages 511-516

  Chao, Tsu Yi ^a   Ho, Ching Liang ^a   Lee, Su Huei ^a   Chen, Mary Mei Ju ^a   Janckila, Anthony ^b   Yam, Lung T ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone metastasis; Breast cancer; Prognostic marker; Tracp activity

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14G6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE METASTASIS; BONE TURNOVER; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; OSTEOCLAST; PRIORITY JOURNAL;

ACID PHOSPHATASE; ADULT; AGE DISTRIBUTION; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE NEOPLASMS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 2642562768     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000077901     Document Type: Article

References (20)

1. Cheng SH, Tsou MH, Liu MC, Jian JJ, Cheng JC, Leu SY, Hsieh CY, Huang AT. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 63:213-223;2000.
2. Fisher B, Ravdin RG, Ausman RK, Slack NH, Moore GE, Noer RJ. Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 168:337-356;1968.
3. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK. Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 15:1337-1345;2000.
4. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Vaananen HK. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 47:597-600;2001.
5. Halleen J, Hentunen TA, Hellman J, Vaananen HK. Tartrate-resistant acid phosphatase from human bone: Purification and development of an immunoassay. J Bone Miner Res 11:1444-1452;1996.
6. Hannon R, Blumsohn A, Naylor K, Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability. J Bone Miner Res 13:1124-1133;1998.
7. Hillner BE, Ingle JN, Berenson JR, Janjan NA, Albain KS, Lipton A, Yee G, Biermann JS, Chlebowski RT, Pfister DG. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. J Clin Oncol 18:1378-1391;2000.
8. Janckila AJ, Takaahashi K, Sun S, Yam LT. Tartrate-resistant acid phosphatase isoforms 5b as serum marker for osteoclastic activity. Clin Chem 47:74-80; 2001.
9. Lam KW, Desnick RJ. Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease. Prog Clin Biol Res 95:267-278;1982.
10. Lam KW, Easstlund DT, Li CY, Yam LT. Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 24:1105-1108;1978.
11. Lam KW, Li CY, Yam LT. Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis. Clin Chem 24:1105-1108;1981.
12. Lipton A, Costa L, Ali S, Demers L. Use of markers of bone turnover for monitoring bone metastases and the response to therapy. Semin Oncol 28(suppl):54-59;2001.
13. Mundy GR. Structure and physiology of the normal skeleton. In: Rubens RD, Mundy GR, eds. Cancer and the Skeleton. London, Dunitz, 1-19;2000.
14. Mundy GR, Guise TA. Pathophysiology of bone metastasis. In: Rubens RD, Mundy GR, eds. Cancer and the Skeleton. London, Dunitz, 43-64;2000.
15. Price CP, Milligan TP, Darte C. Direct comparison of performance characteristics of two immunoassays for bone isoforms of alkaline phosphatase in serum. Clin Chem 43:2052-2057;1997.
16. Rubens RD. Bone metastases - incidence and complications. In: Rubens RD, Mundy GR, eds. Cancer and the Skeleton. London, Dunitz, 33-42;2000.
17. Takahashi K, Janckila AJ, Sun SZ, Sun SZ, Lederer ED, Ray PC, Yam LT. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis. Clin Chim Acta 301:147-158;2000.
18. Vinholes J, Coleman R, Eastell R. Effects of bone metastases on bone metabolism: Implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev 22:289-331;1996.
19. Wada N, Ishii S, Ikeda T, Enomoto K, Kitakima M. Serum tartrate-resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res 19:4515-4521;1999.
20. Yaziji H, Janmckila AJ, Lear SC, Martin AW, Yam LT. Immunohistochemical detection of tartrate-resistant acid phosphatase in nonhematopoietic human tissues. Am J Clin Pathol 104:397-402;1995.